HIV Prevention Methods
The Latest
This Week in HIV Research: It’s Not Just About HIV
June 3, 2021: Kaposi sarcoma despite ART; heat-based cervical HPV treatment; re-evaluating HIV-associated neurocognitive disorder; HIV and diabetes in Texas.
Sexual Health Literacy for Providers Is Crucial to Ending the HIV Epidemic
New York physicians, physician assistants, and nurses may soon be required to talk about sex, gender identity, STIs, and HIV.
This Week in HIV Research: Missing the Message
May 13, 2021: Disparities in U=U awareness; sexual satisfaction trends among PLWH; PrEP use among cis women; HCV epidemiology in trans women.
Oregon Poised to Be Third State to Allow Pharmacist-Prescribed PrEP
Will Oregon’s new bill allowing PrEP without a doctor's prescription improve upon similar laws in California and Colorado?
Traditional Healers Offer a Culturally Competent Approach to HIV Testing Gaps
In sub-Saharan Africa, herbalists and spiritual healers are working closely with researchers to help reduce HIV transmission in rural communities.
This Week in HIV Research: We Need to Better Serve Our Teens
April 8, 2021: PrEP “contemplation” and uptake among adolescents; adolescent perception of HIV risk; HIV diagnosis rates among transgender people; PrEP and HIV incidence in Scotland.
HIV Data Bites: Recent Advances in Broadly Neutralizing Antibodies for HIV Prevention
While findings from the high-profile AMP studies have excited scientists, they’re only one of a wide range of bNAb avenues currently being pursued.
As CROI 2021 Attests, the PrEP Revolution Is Coming
Analysis from David Alain Wohl, M.D., on new research in on HIV prevention, especially in areas that will expand and transform PrEP options.
Long-Acting ART Is Here. How Do We Make It Work for Our Patients?
Injectable HIV interventions are a game-changing new option for people dealing with pill fatigue, but there are implementation challenges for clinicians to consider.
Broadly Neutralizing Antibodies for HIV? If We Can Do It for COVID ...
David Alain Wohl, M.D., shares his thoughts on broadly neutralizing antibodies for COVID-19—and the extent to which we can hope to see similar developments in HIV.